Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication Courtesy Debra Dillo There’s a pill on the ...

What Is Addyi, and Why Does It Matter? Addyi (flibanserin) is a nonhormonal prescription pill that is now approved by the FDA to treat low sexual desire in women younger than 65, including those who ...

Earlier this month the makers of, Addyi—the beleaguered drug many have misguidedly labeled the “female Viagra,”—announced that the little pink pill is relaunching after years of controversy, a ...

You may have heard about Addyi (flibanserin), a nonhormonal medicine approved by the FDA to treat low sex drive, also called hypoactive sexual desire disorder (HSDD) in women less than 65 years old.

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The "little pink pill" is now available to even more women. The Food and Drug ...

Sprout Pharmaceuticals' female libido drug Addyi has traveled a winding path through FDA gatekeepers, multiple M&A deals, marketing restrictions and more. With a possible new safety flag, the ...

Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...

Share on Pinterest Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The FDA expanded its approval ...

R. Jared Staudt raises some valid concerns about the FDA’s recent approval of Addyi, a drug that has been popularly touted as the “female Viagra.” Professor Staudt is right to be concerned that the ...